Importantly, THZ1 and panobinostat combination therapy synergistically reduced tumor progression and resulted in tumor regression in mice xenografted with empty vector SK-N-AS cells, but only moderately suppressed tumor progression in mice xenografted with SK-N-AS cells transfected with JMJD6 ORF (Fig. 7e). Here, JMJD6 is linked to neoplasm.